Los Angeles, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation/CME Surveys
>Registration
>Privacy Policy
 

Check us out on Twitter!

@LA_HeartFailure
 

Sponsored by:
PIH Health Good Samaritan Hospital
Los Angeles, CA

Endorsed by:

Affiliated With:
INTERNATIONAL ACADEMY OF CARDIOLOGY

Related Conferences:


26th Annual

Heart Failure 2022
An Update on Therapy
March 4 & 5, 2022

PROGRAM / SCHEDULE

Friday, March 4, 2022

12:30-12:45
Introduction to the 26th Annual Symposium:
Heart Failure 2022 - An Update on Therapy
     Uri Elkayam, MD

SESSION I

12:45-1:05
The New Universal Definition and Classification of Heart Failure
     Biykem Bozkurt, MD, PhD

1:05-1:25
What is New in the 2021 ESC Guidelines for the Diagnosis and Treatment of Heart Failure?
     Marco Metra, MD

1:25-1:35
New Drug Options for the Management of Heart Failure with Mildly Reduced and Preserved Ejection Fraction
     Carolyn Lam, MD

1:35-1:55
Recommendations for Genetic Testing in Patients with Cardiomyopathies
     Ray Hershberger, MD

1:55-2:05 Break/Visit Virtual Exhibit Hall

2:05-3:05 Product Theatre I

SESSION II

3:10-3:30
Update on the Treatment of HFrEF: The Rational for Simultaneous Initiation of Therapy
     Gregg Fonarow, MD

3:30-3:50
The Role of Vericiguat and Omecamtiv Mecarbil in the Management of Chronic HFrEF
     Kirkwood Adams, MD

3:50-4:10
Potassium Binding in Heart Failure Management - Enabling Guideline Recommended RAASI Therapy
     Uri Elkayam, MD

4:10-4:30
How to Maximize the Use of Guideline Recommended Drug Therapy in Patients with Chronic Heart Failure
     Nancy Albert, PhD

4:35-5:35 Product Theatre II

Saturday, March 5, 2022

7:45-8:45AM Product Theatre III

SESSION III

8:50-9:10
Heart Failure in Hispanic Patients
     Ileana Piņa, MD

9:10-9:30
Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients
     Alanna A. Morris, MD

9:30-9:50
Management of Heart Failure in Patients with Congenital Heart Disease
     Lucy Roche, MD

9:50-10:00 Break/Visit Virtual Exhibit Hall

SESSION IV

10:00-11:00
Supported CE Seminar
Pulmonary Arterial Hypertension and Post-Capillary Pulmonary Hypertension Related to Left Heart Disease
     Barry Greenberg, MD

Supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

SESSION V

11:00-11:20
Myocardial Viability Assessment Before Surgical Revascularation in Ischemic Cardiomyopathy
     Julio A. Panza, MD

11:20-11:30
Impact of Percutaneous Coronary Interventions on the Outcomes of Patients with Heart Failure
     Puja B. Parikh, MD

11:30-11:50 Break/Visit Virtual Exhibit Hall

11:50-12:50 Product Theatre IV

SESSION VI

1:00-1:20
Hemodynamically Guided Classification and Management of Cardiogenic Shock
     James Fang, MD

1:20-1:40
Device Therapy in Chronic Heart Failure
     Marat Fudim, MD

1:40-2:00
Catheter Ablation for Atrial Fibrillation with Heart Failure: Results of Recent Trials and Clinical Implications
     Anil Bhandari, MD

2:00-2:20
Percutaneous Mitral Valve Repair in Patients with Heart Failure - Recommendations for Patient Selection
     Steven Burstein, MD

2:20-2:40
Percutaneous Mitral and Tricuspid Valve Replacement - A Status Report
     Raj Makkar, MD

2:40-2:50 Break/Visit Exhibits

2:50-3:10
Methamphetamine Cardiomyopathy - Clinical Characteristics and Management
     Uri Elkayam, MD

3:10-3:30
Pitfalls in the Diagnosis of Cardiac Amyloidosis
     Mirnela Byku, MD, PhD, MBA

3:30-3:50
A Search for Treatment for Peripartum Cardiomyopathy
     Dennis McNamara, MD

3:50-4:10
Hypertrophic Cardiomyopathy: A Practical Approach to Guideline Directed Management
     Steve R. Ommen, MD, FACC, FAHA

4:10-4:40
The 26th Annual Heart Failure 2022 Keynote Lecture: Surgical Approach to Hypertrophic Cardiomyopathy
     Hartzell Schaff, MD

4:45-5:45 Product Theatre V